Anais Anton

Ms. Anais Anton

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2021 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
AAAnais Anton
Anais Anton
CMClément Mazeaud
Clément Mazeaud
WFwesley freppel
wesley freppel
CGClaudia Gilbert
Claudia Gilbert
NTNicolas Tremblay
Nicolas Tremblay
LCLaurent Chatel-Chaix
Laurent Chatel-Chaix
With no available therapies, infections with Zika virus (ZIKV) constitute a major public health concern as they can lead to congenital microcephaly. In order to generate an intracellular environment favourable to viral replication, ZIKV induces endomembrane remodelling and the morphogenesis of replication factories via enigmatic mechanisms. In this study, we identified the AAA+ type ATPase valosin‐containing protein (VCP) as a cellular interaction partner of ZIKV non‐structural protein 4B (NS4B). Importantly, its pharmacological inhibition as well as the expression of a VCP dominant‐negative mutant impaired ZIKV replication. In infected cells, VCP is relocalised to large ultrastructures containing both NS4B and NS3, which are reminiscent of dengue virus convoluted membranes. Moreover, short treatment with the VCP inhibitors NMS‐873 or CB‐5083 drastically decreased the abundance and size of ZIKV‐induced convoluted membranes. Furthermore, NMS‐873 treatment inhibited ZIKV‐induced mitochondria elongation previously reported to be physically and functionally linked to convoluted membranes in case of the closely related dengue virus. Finally, VCP inhibition resulted in enhanced apoptosis of ZIKV‐infected cells strongly suggesting that convoluted membranes limit virus‐induced cytopathic effects. Altogether, this study identifies VCP as a host factor required for ZIKV life cycle and more precisely, for the maintenance of viral replication factories. Our data further support a model in which convoluted membranes regulate ZIKV life cycle by impacting on mitochondrial functions and ZIKV‐induced death signals in order to create a cytoplasmic environment favourable to viral replication.

18 October 2021 in Viruses
Verified
Journal Article
Open access
PDF file
CMClement Mazeaud
Clement Mazeaud
AAAnais Anton
Anais Anton
FPFelix Pahmeier
Felix Pahmeier
ASAïssatou Aïcha Sow
Aïssatou Aïcha Sow
BCBerati Cerikan
Berati Cerikan
LCLaurent Chatel-Chaix
Laurent Chatel-Chaix
The dengue virus (DENV) causes the most prevalent arthropod-borne viral disease worldwide. While its incidence is increasing in many countries, there is no approved antiviral therapy currently available. In infected cells, the DENV induces extensive morphological alterations of the endoplasmic reticulum (ER) to generate viral replication organelles (vRO), which include convoluted membranes (CM) and vesicle packets (VP) hosting viral RNA replication. The viral non-structural protein NS4B localizes to vROs and is absolutely required for viral replication through poorly defined mechanisms, which might involve cellular protein partners. Previous interactomic studies identified the ATPase valosin-containing protein (VCP) as a DENV NS4B-interacting host factor in infected cells. Using both pharmacological and dominant-negative inhibition approaches, we show, in this study, that VCP ATPase activity is required for efficient DENV replication. VCP associates with NS4B when expressed in the absence of other viral proteins while in infected cells, both proteins colocalize within large DENV-induced cytoplasmic structures previously demonstrated to be CMs. Consistently, VCP inhibition dramatically reduces the abundance of DENV CMs in infected cells. Most importantly, using a recently reported replication-independent plasmid-based vRO induction system, we show that de novo VP biogenesis is dependent on VCP ATPase activity. Overall, our data demonstrate that VCP ATPase activity is required for vRO morphogenesis and/or stability. Considering that VCP was shown to be required for the replication of other flaviviruses, our results argue that VCP is a pan-flaviviral host dependency factor. Given that new generation VCP-targeting drugs are currently evaluated in clinical trials for cancer treatment, VCP may constitute an attractive broad-spectrum antiviral target in drug repurposing approaches.